Find a Doctor
Marwan Sabbagh, MD, FAAN
Alzheimer's and Memory Disorders
- (602) 406-6262
- Fax: (602) 406-6261
More than 400 peer-reviewed publications
Site principal investigator on more than 100 clinical studies
Author of six books
Global principal investigator on more than 10 studies
Marwan Sabbagh, MD, is a behavioral neurologist and the Moreno Family Chair for Alzheimer’s Research in the Alzheimer’s and Memory Disorders Program at Barrow Neurological Institute. He is also a professor and the Vice Chair of Research in the Institute’s Department of Neurology. He is board certified in neurology by the American Board of Psychiatry and Neurology.
Dr. Sabbagh’s expertise includes the diagnosis and treatment of Alzheimer’s disease and other memory disorders. He is a fellow of the American Academy of Neurology.
Dr. Sabbagh earned his medical degree from the University of Arizona College of Medicine in Tucson and his undergraduate degree from the University of California—Berkeley. He completed his neurology residency at Baylor College of Medicine in Houston, Texas, and a geriatric neurology and dementia fellowship at the University of California San Diego School of Medicine.
Dr. Sabbagh is a leading investigator of many prominent national Alzheimer’s prevention and treatment clinical trials. He serves on the editorial boards of the Journal of Alzheimer’s Disease and Alzheimer’s and Dementia: Translational Research & Clinical Interventions. He is the editor-in-chief of Neurology and Therapy. Dr. Sabbagh is a prolific author who has written and edited books on Alzheimer’s disease and has contributed to hundreds of medical and scientific articles.
- Aetna
- AHCCS (Referral Required)
- Blue Cross Blue Shield
- Blue Cross Blue Shield Third Party
- Cigna
- Commercial Networks
- Government Plans
- Humana
- Market Place Plans (Referral Required)
- Medicare Advantage Plans (Referral Required)
- United Healthcare
- Fellowship, University of California San Diego School of Medicine, Department of Neurosciences, Geriatric Neurology and Dementia, 1995-1997
- Residency, Baylor College of Medicine, 1992-1995
- Internship, Banner—University Medical Center Phoenix, Internal Medicine, 1991-1992
- MD, University of Arizona College of Medicine, 1991
- BA, University of California—Berkeley, 1987
- Fellow, American Academy of Neurology
- Innovator Award, WESTMARC, 2015
- Fellow, American Academy of Neurology, 2004
- Finalist, Healthcare Hero Award, Arizona Business Journal, 2004
- Life Member, National Registry of Who’s Who, 2001
- Dystonia Doctor of Excellence, San Diego County, 2000
- Co-recipient, Peter F. Drucker Award, Drucker Institute, 1998
- Travel Fellowship Award, American Neurological Association, 1996
- Finalist, Alistair Karmody Award, 1991
- Student Representative of Western Federation of Clinical Research, University of Arizona, 1990
- Student Summer Fellow, Arizona Cancer Society, 1988
A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce
Date: 08/2024
Authors: Ozioma C. Okonkwo, Monica Rivera Mindt, Miriam T. Ashford, Catherine Conti, Joe Strong, Rema Raman, Michael C. Donohue, Rachel L. Nosheny, Derek Flenniken, Melanie J. Miller, Adam Diaz, Annabelle M. Soto, Beau M. Ances, Maryam R. Beigi, P Murali Doraiswamy, Ranjan Duara, Martin R. Farlow, Hillel T. Grossman, Jacobo E. Mintzer, Christopher Reist, Emily J. Rogalski, Marwan N. Sabbagh, Stephen Salloway, Lon S. Schneider, Raj C. Shah, Ronald C. Petersen, Paul S. Aisen, Michael W. Weiner
Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review
Date: 08/2024
Authors: Elise E. Dunning, Boris Decourt, Nasser H. Zawia, Holly A. Shill, Marwan N. Sabbagh
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease
Date: 07/2024
Authors: Lawrence S. Honig, Marwan N. Sabbagh, Christopher H. van Dyck, Reisa A. Sperling, Steven Hersch, Andre Matta, Luigi Giorgi, Michelle Gee, Michio Kanekiyo, David Li, Derk Purcell, Shobha Dhadda, Michael Irizarry, Lynn Kramer
Conjugal Synucleinopathies: A Clinicopathologic Study
Date: 07/2024
Authors: Charles H. Adler, Matthew Halverson, Nan Zhang, Holly A. Shill, Erika Driver-Dunckley, Shyamal H. Mehta, Alireza Atri, John N. Caviness, Geidy E. Serrano, David R. Shprecher, Christine M. Belden, Marwan N. Sabbagh, Kathy Long, Thomas G. Beach
Updated safety results from phase 3 lecanemab study in early Alzheimer's disease
Date: 05/2024
Authors: Lawrence S. Honig, Marwan N. Sabbagh, Christopher H. van Dyck, Reisa A. Sperling, Steven Hersch, Andre Matta, Luigi Giorgi, Michelle Gee, Michio Kanekiyo, David Li, Derk Purcell, Shobha Dhadda, Michael Irizarry, Lynn Kramer
- English
- (602) 406-6262
- Fax: (602) 406-6261
Marwan Sabbagh, MD, FAAN
Alzheimer's and Memory Disorders
- (602) 406-6262
- Fax: (602) 406-6261
More than 400 peer-reviewed publications
Site principal investigator on more than 100 clinical studies
Author of six books
Global principal investigator on more than 10 studies
Marwan Sabbagh, MD, is a behavioral neurologist and the Moreno Family Chair for Alzheimer’s Research in the Alzheimer’s and Memory Disorders Program at Barrow Neurological Institute. He is also a professor and the Vice Chair of Research in the Institute’s Department of Neurology. He is board certified in neurology by the American Board of Psychiatry and Neurology.
Dr. Sabbagh’s expertise includes the diagnosis and treatment of Alzheimer’s disease and other memory disorders. He is a fellow of the American Academy of Neurology.
Dr. Sabbagh earned his medical degree from the University of Arizona College of Medicine in Tucson and his undergraduate degree from the University of California—Berkeley. He completed his neurology residency at Baylor College of Medicine in Houston, Texas, and a geriatric neurology and dementia fellowship at the University of California San Diego School of Medicine.
Dr. Sabbagh is a leading investigator of many prominent national Alzheimer’s prevention and treatment clinical trials. He serves on the editorial boards of the Journal of Alzheimer’s Disease and Alzheimer’s and Dementia: Translational Research & Clinical Interventions. He is the editor-in-chief of Neurology and Therapy. Dr. Sabbagh is a prolific author who has written and edited books on Alzheimer’s disease and has contributed to hundreds of medical and scientific articles.
- (602) 406-6262
- Fax: (602) 406-6261
- Aetna
- AHCCS (Referral Required)
- Blue Cross Blue Shield
- Blue Cross Blue Shield Third Party
- Cigna
- Commercial Networks
- Government Plans
- Humana
- Market Place Plans (Referral Required)
- Medicare Advantage Plans (Referral Required)
- United Healthcare
- Fellowship, University of California San Diego School of Medicine, Department of Neurosciences, Geriatric Neurology and Dementia, 1995-1997
- Residency, Baylor College of Medicine, 1992-1995
- Internship, Banner—University Medical Center Phoenix, Internal Medicine, 1991-1992
- MD, University of Arizona College of Medicine, 1991
- BA, University of California—Berkeley, 1987
- Fellow, American Academy of Neurology
- Innovator Award, WESTMARC, 2015
- Fellow, American Academy of Neurology, 2004
- Finalist, Healthcare Hero Award, Arizona Business Journal, 2004
- Life Member, National Registry of Who’s Who, 2001
- Dystonia Doctor of Excellence, San Diego County, 2000
- Co-recipient, Peter F. Drucker Award, Drucker Institute, 1998
- Travel Fellowship Award, American Neurological Association, 1996
- Finalist, Alistair Karmody Award, 1991
- Student Representative of Western Federation of Clinical Research, University of Arizona, 1990
- Student Summer Fellow, Arizona Cancer Society, 1988
A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce
Date: 08/2024
Authors: Ozioma C. Okonkwo, Monica Rivera Mindt, Miriam T. Ashford, Catherine Conti, Joe Strong, Rema Raman, Michael C. Donohue, Rachel L. Nosheny, Derek Flenniken, Melanie J. Miller, Adam Diaz, Annabelle M. Soto, Beau M. Ances, Maryam R. Beigi, P Murali Doraiswamy, Ranjan Duara, Martin R. Farlow, Hillel T. Grossman, Jacobo E. Mintzer, Christopher Reist, Emily J. Rogalski, Marwan N. Sabbagh, Stephen Salloway, Lon S. Schneider, Raj C. Shah, Ronald C. Petersen, Paul S. Aisen, Michael W. Weiner
Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review
Date: 08/2024
Authors: Elise E. Dunning, Boris Decourt, Nasser H. Zawia, Holly A. Shill, Marwan N. Sabbagh
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease
Date: 07/2024
Authors: Lawrence S. Honig, Marwan N. Sabbagh, Christopher H. van Dyck, Reisa A. Sperling, Steven Hersch, Andre Matta, Luigi Giorgi, Michelle Gee, Michio Kanekiyo, David Li, Derk Purcell, Shobha Dhadda, Michael Irizarry, Lynn Kramer
Conjugal Synucleinopathies: A Clinicopathologic Study
Date: 07/2024
Authors: Charles H. Adler, Matthew Halverson, Nan Zhang, Holly A. Shill, Erika Driver-Dunckley, Shyamal H. Mehta, Alireza Atri, John N. Caviness, Geidy E. Serrano, David R. Shprecher, Christine M. Belden, Marwan N. Sabbagh, Kathy Long, Thomas G. Beach
Updated safety results from phase 3 lecanemab study in early Alzheimer's disease
Date: 05/2024
Authors: Lawrence S. Honig, Marwan N. Sabbagh, Christopher H. van Dyck, Reisa A. Sperling, Steven Hersch, Andre Matta, Luigi Giorgi, Michelle Gee, Michio Kanekiyo, David Li, Derk Purcell, Shobha Dhadda, Michael Irizarry, Lynn Kramer
- English